Frequency of atherosclerotic cardiovascular disease and its risk factors in patients with systemic lupus erythematosus;Freqüência de doença cardiovascular aterosclerótica e de seus fatores de risco em pacientes com lúpus eritematoso sistêmico

Revista Brasileira de Reumatologia

Volumn 47, Issue 3, 2007, Pages 165-173

  Telles, Rosa Weiss ^a   Lanna, Cristina Costa Duarte ^b   Ferreira, Gilda Aparecida ^c   de Carvalho, Marco Antonio Parreiras ^b   Ribeiro, Antonio Luiz ^b  

^a Projeto Pronuclear da Sociedade Brasieleira de Reumatologia ^*  (Brazil)

^b UFMG   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atherosclerosis; Cardiovascular disease; Risk factors for coronary disease; Systemic lupus erythematosus

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BRAZIL; CARDIOVASCULAR DISEASE; CLINICAL LABORATORY; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MENOPAUSE; RISK FACTOR; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 51649110430     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Barr SG, Zonana-Nacach A, Magder LS, Petri M: Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum 42:2682-8, 1999.
2. Bessant R, Hingorani A, Patel L, MacGregor A, Isemberg DA, Rahman A: Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology 43:924-9, 2004.
3. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R: Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44:2331-7, 2001.
4. Manzi S, Meilahn EN, Rairie JE, et al.: Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 145:408-15, 1997.
5. Aranow C, Ginzler EM: Epidemiology of cardiovascular disease in systemic lupus erythematosus. Lupus 9:166-9, 2000.
6. Petri M, Perez-Gutthann S, Spence D, Hochberg MC: Risk factors fbr coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93:513-9, 1992.
7. Gladman DD, Urowitz MB: Morbidity in systemic lupus erythematosus. J Rheumatol 14:223-6, 1987.
8. Rahman P, Gladman DD, Urowitz MB, Yuen K, Hallett D, Bruce IN: The cholesterol lowering effect of antimalariats drugs is enhanced in patients with lupus taking corticosteroid drugs. J Rheumatol 26:325-30, 1999.
9. Souza AWS, Hatta FS, Miranda JF, Sato EI: Atherosclerotic plaque in carotid arteries in systemic lupus erythematosus frequency and associated risk factors. Sõ Paulo Medical Journal 123:137-42, 2005.
10. Bruce IN, Urowitz MB, Gladman DD, Ibanes D, Steiner G: Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto risk factor study. Arthritis Rheum 48:3159-67, 2003.
11. Rahman P, Aguero S, Gladman DD, Hallett D, Urowitz MB: Vascular events in hypertensive patients with systemic lupus erythematosus. Lupus 9:672-5, 2000.
12. Toloza SMA, Uribe AG, McGwin G-Jr, et al.: Systemic lupus erythematosus in a multiethinic US cohort (LUMINA): XXIII. Baseline predictors of vascular events. Arthritis Rheum 50: 3947-57, 2004.
13. Petri M, Spence D, Bone LB, Hochberg MC: Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices. Medicine 71:291-302, 1992.
14. Costenbader KH, Wright E, Liang MH, Karlson EW. Cardiac risk factor awareness and management in patients with systemic lupus erythematosus. Arthritis Rheum 51:983-8, 2004.
15. Urowitz MB, Gladman DD, Fortin PR, et al.: Systemic Lupus International Collaborating Clinics (SLICC) inception cohort registry to study risk factors for atherosclerosis: accumulation of atherosclerotic risk factors over 3 years. Arthritis and Rheumatism 54:S521, 2006.
16. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults - Executive Summary of the third report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel III). JAMA 285:2486-97, 2001.
17. Wajed J, Ahmad Y, Durrington PN, Bruce IN: Prevention of cardiovascular disease in systemic lupus erythematosus - proposed guidelines for risk factor management. Rheumatology 43:7-12, 2004.
18. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of the systemic lupus erythematosus (letter). Arthritis Rheum 40:1725, 1997.
19. Tam EM, Cohen AS, Fries JF: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271, 1982.
20. a ed. Londres, Fiona Foley, 1998.
21. Wilson WA, Gharavi AE, Koike T, et al.: International consensus statement on preliminary classification criteria for definite antiohosphohpid syndrome-Report of an international workshop. Arthritis Rheum 42:1309-11, 1999.
22. Gladman DD, Ginzler EM, Goldsmith C, et al.: The Development and initial validation of the Systemic Lupus International Collaborating Clinics/ American College of Rheumato1gy damage index for systemic lupus erythematosus. Arthritis Rheum 39:363-9, 1996.
23. European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioral Medicine, European Society of General Practice/Family Medicine, European Heart Network: Prevention of coronary heart disease in clinical practice: recommendations of the second Joint Task Force of European and the other Societies on coronary prevention. Eur Heart J 19:1434-503, 1998.
24. Diagnosis and classification of Diabetes Mellitus - American Diabetes Association. Diabetes Care 27:S5-S10, 2004.
25. O'Leary DH, Polak JF, Kronmal RA, et al.: Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke 23:1752-60, 1992.
26. Theodoridou A, Bento L, D'Cruz DP, Khamashta MA, Hughes GRV: Prevalence and association of an abnormal ankle-brachial in systemic lupus erythematosus: a pilot study. Ann Rheum Dis 62:1199-203, 2003.
27. Prevenção clínica de doenčas cardiovascular, cerebrovascular e renal - Manual prático para profissionais do Sistema Único de Saúde - Caderno de atenção básica - Estimativa de risco global e prevenção. Ministério da Saúde - Secretaria de Atençãoà Saúde - Departamento de Atenção Especializada/Coordenação Geral de Alta Complexidade - Coordenação de Hipertensão e Diabetes, ed., 2006.
28. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-47, 1998.
29. Urowitz MB, Gladman DD, Ibanez D, et al.: Systemic Lupus international Collaborating Clinics (SLICC) inception cohort registry to study risk factors for atherosclerosis: report on the first 852 patients. Arthritis Rheum 54:S281, 2006.
30. Sella EMC, Sato EI: Avaliação de fatores de risco coronário e dor torácica em lúpus eritematoso sistêmico. Rev Bras Reumatol 42:160-8, 2002.
31. Barreto SM, Passos VMA, Cardoso ARA, Lima-Costa MF: Quantificando o risco de doença coronariana na comunidade de Bambuí. Arq Bras Cardiol 81:549-55, 2003.
32. Avalos I, Chung CP, Oeser A, et al.: Decreased insulin sensitivity in systemic lupus erythematosus is associated with inflammation and cardiovascular risk factors. Arthritis Rheum 54:S271, 2006.
33. Toloza S, Chandran V, Gladman DD, Ibanes D, Urowitz M: Metabolic Syndrome in SLE: increased prevalence and associations with disease manifestations. Arthritis Rheum 54:S434, 2006.
34. Urowitz MB, Gladman DD, Fortin PR, et al.: Systemic Lupus International Collaborating Clinics (SLICC) inception cohort regstry to study nsk fiwtors for atherosclerosis: metabolic syndrome, prevalence and associated factors. Arthritis Rheum 54:S282, 2006.
35. Botha EF, Bonfá E: Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipins antibodies. Lupus 6:533-9, 1997.
36. Bruce IN, Urowitz MB, Gladman DD, Hallett DC: Natural history of hypercholesterolemia in systemic lupus erythematosus. J Rheumatol 26:2137-43, 1999.